Approval · Notice of Compliance 3206 · 1998
SAIZEN: Notice of Compliance 3206
Issued May 13, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3206
- Date
- May 13, 1998
- Company
- Serono Canada Inc.
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing, new strength
- Therapeutic class
- Human growth hormone
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SAIZEN | 02237970 | Cancelled Pre Market |
| SAIZEN | Not yet assigned | — |
Medicinal ingredients
- SOMATROPIN 1.33 MG per VIAL
- SOMATROPIN 3.33 MG per VIAL